菲尔戈提尼布通过调节JAK1/STAT3/SOCS3/IL-17A信号来改善实验性肺纤维化
Yunying Lv1, Guanghua Zhang2, Dexin Kong1
1School of Pharmacy, Binzhou Medical University, Yantai, China.
Basic & clinical pharmacology & toxicology
|February 25, 2025
概括
菲尔戈提尼布是一种JAK1抑制剂,通过减少纤维细胞增殖,在治疗肺纤维化方面表现有前途. 这项研究研究了它在大鼠模型中的保护作用和机制,揭示了JAK1/STAT3/SOCS3/IL-17A通路的抑制.
科学领域:
- 药理学 药理学是指药理学的学科.
- 肺部医学 肺部医学
- 免疫学 免疫学 免疫学
背景情况:
- 菲尔戈提尼布已被批准用于类风湿性关节炎,但其在肺纤维化中的作用尚不清楚.
- 肺纤维化是一种渐进的肺病,治疗选择有限.
研究的目的:
- 在肺纤维化实验模型中研究菲尔戈提尼布的疗效.
- 阐明菲尔戈提尼布在抑制肺纤维化中的作用机制.
主要方法:
- 一项使用白胺诱导的肺纤维化在用菲尔戈提尼布治疗的老鼠身上进行的体内研究.
- 在体外实验中评估菲尔戈蒂尼布对TGF-β1诱导的小鼠肺纤维细胞增殖的影响.
- 分析蛋白质表达水平,包括IL-17A,p-JAK1,p-STAT3和SOCS3.3.
主要成果:
- 在大鼠模型中,菲尔戈提尼布治疗改善了肺功能和病理.
- 菲尔戈蒂尼布在体外减少了纤维细胞的增殖.
- 菲尔戈提尼布调节了JAK1/STAT3/SOCS3/IL-17A通路中的关键蛋白质的表达.
结论:
- 菲尔戈提尼布表明对实验性肺纤维化有保护作用.
- 该机制涉及通过JAK1/STAT3/SOCS3/IL-17A通路抑制纤维细胞增殖.
关键词:
在IL-17AA中.詹姆斯1的第一名.在 SOCS3 中,SOCS3 是 SOCS3 的代名词.在STAT3中,我们可以使用STAT3.菲尔戈提尼布 (filgotinib) 是一种药物.肺部纤维化 肺部纤维化更多相关视频
06:29Adoptive Transfer of IL-33-Stimulated Macrophages into Bleomycin-Induced Mouse Models to Study Their Effect on Idiopathic Pulmonary Fibrosis In Vivo
Published on: May 5, 2023
2.2K
07:38A Multimodal Imaging Approach Based on Micro-CT and Fluorescence Molecular Tomography for Longitudinal Assessment of Bleomycin-Induced Lung Fibrosis in Mice
Published on: April 13, 2018
11.4K
相关概念视频
The JAK-STAT Signaling Pathway
8.6K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.6K
Intracellular Signaling Affects Focal Adhesions
2.5K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
2.5K
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
TGF - β Signaling Pathway
7.2K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K
